Yamasa Ramps Up API CMO Biz for Oligonucleotides, mRNA Drugs amid Changes in Modalities

August 19, 2021
Toshitada Noguchi, Managing Director, Biochemicals Division, Yamasa Major Japanese soy sauce maker Yamasa is poised to ratchet up its contract business for API manufacturing and process development for nucleic acid-based therapeutics - oligonucleotides and mRNA drugs - in a bid...read more